Literature DB >> 8395385

Intravenous morphine depresses the transmission of noxious messages to the nucleus centralis of the amygdala.

G F Huang1, J M Besson, J F Bernard.   

Abstract

It has recently been demonstrated that the nucleus centralis of the amygdala contains numerous neurons specifically driven by noxious stimuli. The aim of the present study was to investigate the effect of i.v. morphine on responses of neurons located in the nucleus centralis of the amygdala to noxious mechanical or thermal stimuli. It was observed, in halothane-anesthetized rats, that i.v. morphine caused a marked depression of responses induced by noxious thermal (waterbath, 50 degrees C) and mechanical (pinch) stimuli and caused a moderate depression of spontaneous activity in a dose-related (1, 3, 9 mg/kg) and naloxone reversible fashion. The ED50 value was 1.2 and 9 mg/kg for i.v. morphine for the evoked activity and spontaneous activity, respectively. The strong depressive effect of morphine on evoked activity probably reflects a direct action of this drug at both spinal and parabrachial levels. These results could account, at least in part, for the effect of morphine on the emotional-affective aspects of pain.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8395385     DOI: 10.1016/0014-2999(93)90484-y

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  DAMGO in the central amygdala alleviates the affective dimension of pain in a rat model of inflammatory hyperalgesia.

Authors:  R-X Zhang; M Zhang; A Li; L Pan; B M Berman; K Ren; L Lao
Journal:  Neuroscience       Date:  2013-08-28       Impact factor: 3.590

2.  The human amygdala and pain: evidence from neuroimaging.

Authors:  Laura E Simons; Eric A Moulton; Clas Linnman; Elizabeth Carpino; Lino Becerra; David Borsook
Journal:  Hum Brain Mapp       Date:  2012-10-25       Impact factor: 5.038

3.  GluA1 in Central Amygdala Promotes Opioid Use and Reverses Inhibitory Effect of Pain.

Authors:  Yuan-Yuan Hou; You-Qing Cai; Zhizhong Z Pan
Journal:  Neuroscience       Date:  2019-12-19       Impact factor: 3.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.